REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
389 employees · est. 2008 · Rockville, United States
Vivet Therapeutics
Vivet Therapeutics develops gene therapy treatments for inherited liver disorders using liver tropic virus.
16 employees · est. 2016 · Paris, France
REGENXBIO is the older company (2008 vs 2016); REGENXBIO is the larger of the two.
Side-by-Side Comparison
| Metric | REGENXBIO | Vivet Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2016 |
| Headquarters | ||
| Headquarters | Rockville, United States | Paris, France |
| Employees | ||
| Employees | 389 larger | 16 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health and Wellness | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | IPO | Grant |
| Total Funding | ||
| Total Funding | $1.58B | $87.40M |
| Funding Rounds | ||
| Funding Rounds | 17 | 4 |
| Services | ||
| Services | Developing Gene Therapy Candidates, Clinical Trials, In-house Manufacturing, Research and Development | Development of transformative gene therapies, AAV-based therapeutic technologies, Research and clinical trials focused on rare diseases, Patient advocacy and support in rare genetic disorders |
| Target Customers | ||
| Target Customers | Patients with Retinal Diseases, Patients with Genetic Disorders, Healthcare Providers, Pharmaceutical Partners | Patients with rare genetic disorders, Healthcare professionals in gene therapy, Biotechnology partners, Investors in healthcare and biotechnology sectors |
| Taxonomy | ||
| Taxonomy | Gene Therapy, AAV Therapeutics, Biopharmaceuticals, Retinal Diseases, Rare Diseases, AAV Vectors, Metabolic Disorders, Muscle Diseases, Hematologic Disorders, Ocular Diseases, Neurodegenerative Disorders, One-time Treatments, Therapeutic Development, Reagent Services | Gene Therapy, Inherited Liver Disorders, Orphan Diseases, Liver Tropic Virus, AAV Vectors, Liver Targeting, Gene Delivery Optimization, Long-term Expression, Collaborative Research, Biotechnology Innovation, Medical Research Partnership |
| Website | ||
| Website | regenxbio.com | vivet-therapeutics.com |
About REGENXBIO
REGENXBIO, founded in 2008, is a clinical-stage biotechnology company based in the United States known for its pioneering work in AAV Therapeutics, a promising class of gene therapy medicines. The company is actively advancing a robust pipeline targeting retinal and rare diseases with products like...
About Vivet Therapeutics
Vivet Therapeutics is a pioneering company within the Biopharma and Biotechnology industries, solidifying its focus on advancing innovative gene therapy treatments specifically for inherited liver disorders. Established in 2016, the company has positioned itself as a leader in treating orphan diseas...
We will tell you when either one moves
BounceWatch watches REGENXBIO and Vivet Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at REGENXBIO and Vivet Therapeutics — by email.
Frequently Asked Questions
Compare REGENXBIO with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at REGENXBIO on 9 Jun 2026, and Vivet Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
